EOLS (STOCKS)
Evolus, Inc. Common Stock
$4.330000
+0.060000 (+1.41%)
Prev close: $4.270000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- David Moatazedi
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $282.33M
- Employees
- 329
- P/E (TTM)
- -5.39
- P/B (TTM)
- -12.18
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
6
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.11 | $-0.18 | +0.0660 | +37.50% |
|
Jun 2025 (Q2)
|
$-0.23 | $-0.11 | -0.1198 | -108.71% |
|
Mar 2025 (Q1)
|
$-0.15 | $-0.15 | -0.0014 | -0.94% |
|
Dec 2024 (Q4)
|
$0.04 | $0.04 | +0.0012 | +3.09% |
Financial Statements
| Revenues | $297.18M |
| Benefits Costs and Expenses | $348.14M |
| Cost Of Revenue | $100.07M |
| Costs And Expenses | $229.77M |
| Gross Profit | $197.11M |
| Operating Expenses | $229.77M |
| Selling, General, and Administrative Expenses | $220.79M |
| Depreciation and Amortization | $4.35M |
| Other Operating Expenses | $4.64M |
| Operating Income/Loss | -$32.66M |
| Income/Loss From Continuing Operations After Tax | -$51.64M |
| Income/Loss From Continuing Operations Before Tax | -$50.96M |
| Income Tax Expense/Benefit | $677.00K |
| Income Tax Expense/Benefit, Current | $656.00K |
| Income Tax Expense/Benefit, Deferred | $21.00K |
| Net Income/Loss | -$51.64M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$51.64M |
| Net Income/Loss Available To Common Stockholders, Basic | -$51.64M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.80 |
| Diluted Earnings Per Share | -$0.80 |
| Basic Average Shares | 64,468,913 |
| Diluted Average Shares | 64,468,913 |
| Assets | $225.87M |
| Current Assets | $142.92M |
| Inventory | $26.96M |
| Prepaid Expenses | $3.76M |
| Other Current Assets | $112.20M |
| Noncurrent Assets | $82.95M |
| Fixed Assets | $5.37M |
| Intangible Assets | $48.04M |
| Other Non-current Assets | $29.54M |
| Liabilities | $248.97M |
| Current Liabilities | $75.31M |
| Accounts Payable | $23.36M |
| Wages | $10.79M |
| Other Current Liabilities | $41.16M |
| Noncurrent Liabilities | $173.67M |
| Long-term Debt | $146.10M |
| Other Non-current Liabilities | $27.57M |
| Equity | -$23.11M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$23.11M |
| Liabilities And Equity | $225.87M |
| Net Cash Flow From Operating Activities | -$42.27M |
| Net Cash Flow From Operating Activities, Continuing | -$42.27M |
| Net Cash Flow From Investing Activities | -$8.45M |
| Net Cash Flow From Investing Activities, Continuing | -$8.45M |
| Net Cash Flow From Financing Activities | $17.34M |
| Net Cash Flow From Financing Activities, Continuing | $17.34M |
| Exchange Gains/Losses | $254.00K |
| Net Cash Flow | -$33.13M |
| Net Cash Flow, Continuing | -$33.38M |
| Comprehensive Income/Loss | -$50.89M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$50.89M |
| Other Comprehensive Income/Loss | -$50.89M |
| Other Comprehensive Income/Loss Attributable To Parent | $749.00K |